Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Get Alerts

Glenmark Pharmaceuticals Ltd

NSE: GLENMARK · BSE: 532296 · Pharmaceuticals & Biotechnology · 39 announcements

Glenmark Pharmaceuticals Ltd news stories on ALFA NewsRead the news →
Share price
₹2,282.30
Market cap
₹64,412 Cr
Revenue (annual)
₹16,983 Cr
Net profit (annual)
₹1,362 Cr
P/E (TTM)
35.8×Sector 47.4×
Promoter holding
46.65%+0.00% QoQ
FII holding
20.89%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 7Product Launch 6Financial Results 4Other Announcement 3Business Update 3Results Update 2Regulatory Approval 2Legal & Regulatory 2Board Meeting Date 2Annual General Meeting 2Merger & Restructuring 1Management Change 1Employee Stock Options 1Dividend 1Debt & Borrowing 1Credit Rating 1

Time

All time Last 1 weekLast 1 monthLast 2 monthsLast 3 monthsLast 6 monthsLast 1 year

2 announcements with these filters

15:30 IST BSE
Board Meeting Date

Glenmark Pharmaceuticals Board Meeting Date

Glenmark Pharmaceuticals scheduled a board meeting on July 31, 2026. The board will consider and approve unaudited financial results for the quarter ended June 30, 2026.

Read the filing ↗
16:48 IST BSE
Board Meeting Date

Glenmark Pharmaceuticals Board Meeting Date

Glenmark Pharmaceuticals scheduled a board meeting for May 29, 2026. Directors will approve FY26 financial results and consider recommending a dividend to shareholders.

Read the filing ↗